Share this post on:

Product Name :
Lestaurtinib

Search keywords :
Lestaurtinib

drugId :
null

Target Vo:
Tyrosine-protein kinase JAK2

Target Vo Short Name :
JAK2

Moa_Name:
Nerve growth factor receptor Trk-A antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Kyowa Hakko Kirin Co Ltd

Active Company_Name :
National Cancer Institute

Active Indication_Name:
Leukemia

In Active Indication_Name:
Bone Marrow Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TrkA Antibody
SPINK1 Antibody (YA1204)
TAP Tag Antibody (YA887): TAP Tag Antibody (YA887) is an unconjugated, mouse-derived, anti-TAP Tag (YA887) monoclonal antibody. TAP Tag Antibody (YA887) can be used for: WB expriments in species-independent background without labeling.

Share this post on:

Author: Betaine hydrochloride